DVx Inc.

Tokyo Stock Exchange:3079.T

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

Location

Japan

Market Cap

USD 67.42 M

Share Price

USD 6.44

Avg Daily Volume

13,632

Change (1 day)

-1.19%

Change (1 year)

3.63%

Change (YTD)

8.20%

DVx Inc. Receivables for the year ending March 31, 2025: USD 86.13 M

DVx Inc. Receivables is USD 86.13 M for the year ending March 31, 2025, a 12.32% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

DVx Inc. Receivables for the year ending March 31, 2024 was USD 76.69 M, a -10.65% change year over year.
DVx Inc. Receivables for the year ending March 31, 2023 was USD 85.83 M, a -9.57% change year over year.
DVx Inc. Receivables for the year ending March 31, 2022 was USD 94.91 M, a -4.33% change year over year.
DVx Inc. Receivables for the year ending March 31, 2021 was USD 99.21 M, a -7.14% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Receivables	Inventory	Current Assets	Property, Plant, Equipment (Net)

Tokyo Stock Exchange: 3079.T

DVx Inc.

CEO	Mr. Hiroshi Shibasaki
IPO Date	April 25, 2007
Location	Japan
Headquarters	Mejiro Nakano Building
Employees	316
Sector	🏥 Health Care
Industries Medical Instruments

Description

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.